Siu L. Lam
Vancouver, BC V5Z4H4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
First pilot study of intravenous rAAV-PAX6 gene therapy increases retinal-ganglion-cell-layer thickness and Notch1 transcription in a mouse model of aniridia.
Journal: Gene therapy
Published: August 13, 2025
ABE8e Corrects Pax6-Aniridic Variant in Humanized Mouse ESCs and via LNPs in Ex Vivo Cortical Neurons.
Journal: Ophthalmology and therapy
Published: March 12, 2023
Germline CRISPR/Cas9-Mediated Gene Editing Prevents Vision Loss in a Novel Mouse Model of Aniridia.
Journal: Molecular therapy. Methods & clinical development
Published: February 19, 2020
Twenty-Seven Tamoxifen-Inducible iCre-Driver Mouse Strains for Eye and Brain, Including Seventeen Carrying a New Inducible-First Constitutive-Ready Allele.
Journal: Genetics
Published: December 20, 2018
PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina.
Journal: Molecular therapy. Methods & clinical development
Published: April 01, 2016
rAAV-compatible MiniPromoters for restricted expression in the brain and eye.
Journal: Molecular brain
Published: January 21, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026